SalvaRx (AIM: SALV), the drug discovery and development company focused on cancer immunotherapy, is pleased to announce that at its Annual General Meeting held earlier today all resolutions set out
Immupharma PLC (LON:IMM) Update on Corporate Activities
ImmuPharma PLC (LSE: IMM), the specialist drug discovery and development company is pleased to provide an update on ongoing activities.
Faron Pharma. Oy (LON:FARN) Patient subgroup identified from INTEREST trial
Dr Markku Jalkanen, CEO of Faron, said: “We have, and are continuing to build, a solid body of evidence which indicates that there is clearly a subgroup of patients for
N4 Pharma PLC (AIM:N4P) Research collaboration update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing a novel delivery system for vaccines and cancer treatments, today provides an update on its collaboration with MedImmune, following the
WideCells Group PLC (AIM:WDC) Board Restructuring and Cost Cutting
The Group’s CEO, João Andrade, said, “I’d like to thank Alan Greenberg for his dedication to WideCells and I wish him all the best for the future.
N4 Pharma PLC (AIM:N4P) Nuvec® research update
Nigel Theobald, CEO of N4 Pharma commented: These results are another positive step forward for our Nuvec® delivery platform.
Canada becomes the second country in the world to legalise recreational marijuana
Canadian Prime Minister Justin Trudeau said Wednesday marijuana will be legal nationwide on October 17.
Eden Research plc (AIM:EDEN) TerpeneTech granted regulatory clearance for head-lice product
Sean Smith, Chief Executive Officer of Eden, said: “The development of this head-lice product has been in progress for approximately three years and it is good to see it
How Theranos CEO Elizabeth Holmes Committed Massive Fraud
Infamous blood testing company Theranos is shutting down — look back at some of the top revelations about its demise
Midatech Pharma PLC (AIM:MTPH) Interim results from MTD201 exploratory study
Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology
David Smith, Chief Operating Officer of Flying Brands Ltd (LON:FBDU) Interview
Zak Mir talks with David Smith about his new appointment and he talks about the background of the business.
